AS1810722
AS1810722 is an orally active and potent STAT6 inhibitor (IC50 :1.9 nM) . AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
477.52
Molecular Formula
C25H25F2N7O
Notes
Research use only, not for human use.
Receptor
CYP3A4|STAT6
CAS Number
909561-15-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6206046-01 0.1 mL
EPHA5 (EPH Receptor A5, CEK7, EHK1, HEK7, TYRO4) (MaxLight 490)
Ask
View Details